Prostate Disease Clinical Trial
Official title:
Evaluation of a Soft Tissue Biopsy System for Trans-rectal and Trans-perineal Biopsy of the Prostate
Currently used biopsy devices do not predictably obtain full cores of tissue and the tissue obtained is often fragmented and disrupted making it difficult for pathological review. This post-market study will assess the utility of the SUREcore biopsy needle and the coreCARE specimen retrieval device versus a standard of care biopsy needle and the typical tissue container used in urology offices and clinics today.
The safety and performance of the SUREcore and coreCARE devices will be compared to matched prostate tissue collected with a standard of care biopsy needle and tissue retrieval system. Following informed consent, prostate tissue biopsy samples will be obtained using the systematic 12 core biopsy template-- 6 with the typical biopsy needle and 6 with the SUREcore needle. Tissue samples will be randomized to retrieval with the swiping method or using the coreCARE device. Adverse events will be documented both during the procedure and within 5 days after the procedure. The user will be asked to rank the use of both biopsy tools during the procedure and a pathologist will be asked to assess the quality of the tissue cores obtained. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04288427 -
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
|
N/A | |
| Completed |
NCT00756561 -
HOP-2A - Intratesticular Hormone Levels
|
N/A | |
| Enrolling by invitation |
NCT03503643 -
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
|
||
| Active, not recruiting |
NCT03543189 -
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT03658408 -
4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy
|
Phase 2 | |
| Recruiting |
NCT04656678 -
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer
|
N/A | |
| Completed |
NCT01307852 -
In Vivo Dosimetry During Prostate Cancer Radiotherapy
|
Phase 1 | |
| Recruiting |
NCT04026763 -
MR/TRUS Fusion Guided Prostate Biopsy
|
N/A | |
| Completed |
NCT05834270 -
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
|
N/A | |
| Completed |
NCT00037141 -
Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT03589196 -
Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT
|
N/A | |
| Recruiting |
NCT05902637 -
The Efficacy Of Mapping For Cognitive Prostate Biopsy
|
N/A | |
| Withdrawn |
NCT03597386 -
ConfirmMDx Assay in Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion Biopsy
|
||
| Completed |
NCT05399940 -
The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters
|
||
| Withdrawn |
NCT04699552 -
Effect of Laser Settings on Postoperative Voiding Symptoms in Patients Undergoing Holmium Laser Enucleation of the Prostate
|
N/A | |
| Completed |
NCT05803096 -
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
|
Phase 4 | |
| Recruiting |
NCT04599218 -
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
|
N/A |